Prevention of Hernia After Loop Ileostomy Reversal
Recruiting
Phase 2
Phase 3
Interventional Study
Loop Ileostomy
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 208 (estimated)
- Sponsor
- Karolinska Institutet · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients operated for low anterior resection for rectal cancer with a diverting loop ileostomy and planned for stoma reversal
Exclusion Criteria:
* Language barrier or cognitive disability
* Recurrent cancer
Contacts